Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sjögren's Syndrome with Double-positive Anti-SS-A and Anti-centromere Antibodies

Intern Med. 2024 Nov 1;63(21):2987-2990. doi: 10.2169/internalmedicine.3384-23. Epub 2024 Mar 4.

Abstract

Sjögren's syndrome (SS) can present with extraglandular organs, such as interstitial lung disease (ILD). Anti-SS-A antibody is frequently found in SS cases, whereas anti-centromere antibody (ACA) is detected in some SS cases. Notably, the anti-SS-A and ACA double-positive cases exhibited distinct features with a higher prevalence of ILD. However, there have so far been no reports on the treatment of ILD in anti-SS-A and ACA double-positive cases. We herein present a case of ILD with anti-SS-A and ACA double-positive SS that was successfully treated with immunosuppressive therapy. Our case suggests the potential efficacy of immunosuppressive therapy for this poorly understood condition.

Keywords: Sjögren's syndrome; anti-SS-A antibody; anti-centromere antibody; immunosuppressive therapy; interstitial lung disease; prognosis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Antinuclear* / blood
  • Antibodies, Antinuclear* / immunology
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Centromere / immunology
  • Humans
  • Immunosuppressive Agents* / therapeutic use
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / etiology
  • Lung Diseases, Interstitial* / immunology
  • Sjogren's Syndrome* / complications
  • Sjogren's Syndrome* / diagnosis
  • Sjogren's Syndrome* / drug therapy
  • Sjogren's Syndrome* / immunology
  • Treatment Outcome

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Immunosuppressive Agents
  • SS-A antibodies